Alchemy Labs Hits TSX Venture: A Look at the Defence-Tech IPO

The company, which secured its funding through a syndicate led by Haywood Securities, is entering the market at a moment when thermal concealment has shifted from a niche requirement to an operational necessity. Alchemy’s core defence technology, Crypsis, utilizes nanoparticle materials to mitigate detection by infrared cameras, a capability increasingly vital as low-cost drones render traditional battlefields transparent. Unlike established defence contractors, Alchemy positions itself as a capital-light enabler, focusing on licensing and material sales to prime contractors rather than manufacturing finished goods.

Beyond the defence vertical, the company maintains a revenue-generating automotive unit, ExoShield, which provides windshield protection film. This segment, which reported $1.7 million in revenue for 2025, serves as a financial stabilizer while the company scales its defence contracts. Alchemy arrives on the exchange backed by field validations from Canada’s Department of National Defence and selection into NATO’s DIANA 2026 cohort. While these milestones provide a degree of early-stage de-risking, the company remains pre-scale, with a prospectus that highlights typical risks including negative operating cash flow and reliance on the non-linear timelines of government procurement.